Group 1 - The core point of the article highlights the continued high enthusiasm for public fund research, with 125 public fund institutions participating in A-share company research during the week of May 12-18, 2025, covering 210 stocks across 76 secondary industries, resulting in a total of 972 research instances [1] - Among the stocks, 69 were researched at least 5 times, with 46 stocks receiving 5-9 instances, 16 stocks receiving 10-19 instances, and 7 stocks being researched at least 20 times [1] Group 2 - The top ten stocks by research frequency were all researched at least 16 times, with Anji Technology leading at 57 instances, attracting over 30% of public fund participation, making it the "research king" [2] - Following Anji Technology, Aobi Zhongguang received 30 public fund institution visits, indicating strong market interest in its 3D vision technology [3] - Huadong Medicine ranked third with 29 research instances, recognized for its growth potential driven by innovative drugs and medical aesthetics [3] Group 3 - The top ten researched stocks were primarily concentrated in technology innovation, healthcare, and consumer sectors, reflecting public funds' strategy to focus on high-quality targets aligned with national industrial policy and long-term growth potential [3] - The semiconductor industry topped the research frequency with 76 instances, indicating strong expectations for domestic semiconductor replacement processes, with companies like Canray Technology and Demingli receiving significant attention [3] - The general equipment industry followed with 60 research instances, showing institutions' intent for comprehensive layout in high-end equipment manufacturing [3]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expectation that the company's stock will outperform the benchmark index by more than 20% over the next 6-12 months [2][6]. Core Views - The company has faced challenges in its zeolite and pharmaceutical segments due to weak downstream demand, but there is optimism regarding the growth potential from its various new material developments [4][9]. - The financial performance for 2024 shows a total revenue of RMB 3.693 billion, a decrease of 14.22% year-on-year, and a net profit attributable to shareholders of RMB 246 million, down 67.72% year-on-year [4][10]. - The report highlights the company's ongoing research and development efforts and the successful progress in new materials, which are expected to drive long-term growth [9][12]. Financial Summary - For 2024, the company reported total revenue of RMB 36.93 billion, with a significant decline in net profit to RMB 2.46 billion, reflecting a 67.72% decrease compared to the previous year [4][10]. - The first quarter of 2025 saw a revenue drop of 8.17% to RMB 861.23 million, with a net profit decrease of 18.76% to RMB 79.87 million [12]. - The earnings per share (EPS) estimates for 2025, 2026, and 2027 are projected to be RMB 0.39, RMB 0.48, and RMB 0.56 respectively, with corresponding price-to-earnings (PE) ratios of 28.4, 23.1, and 19.6 [6][8]. Business Segment Performance - The functional materials segment generated RMB 30.19 billion in revenue for 2024, down 10.30% year-on-year, with a gross margin of 39.96% [9]. - The company has maintained its leading position in high-end liquid crystal monomer materials and has seen good development in OLED materials, while also making progress in semiconductor manufacturing materials [9][12]. - The life sciences and pharmaceutical business experienced a revenue decline of 28.65% to RMB 6.29 billion in 2024, although the gross margin improved to 38.16% [9]. Future Outlook - The company is expected to expand its production capacity in functional materials, with the first phase of the Penglai project set to gradually come online in the first half of 2025 [9]. - The report emphasizes the potential for growth in various new materials, including applications in the petrochemical sector and advancements in OLED and semiconductor materials [9][12].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company achieved significant growth in both revenue and net profit, with a 2024 total revenue of 3.338 billion yuan, up 25% year-on-year, and a net profit of 521 million yuan, up 135% year-on-year. In Q1 2025, revenue reached 824 million yuan, up 16% year-on-year, and net profit was 141 million yuan, up 73% year-on-year. The company is expected to maintain double-digit growth in revenue and over 100% growth in net profit for 2025 [3][4] - The company is positioned as a key player in the import substitution of innovative materials, with a focus on semiconductor materials and a strong platform strategy. Revenue forecasts for 2025-2027 are adjusted to 3.973 billion yuan, 4.859 billion yuan, and 5.729 billion yuan respectively, with net profit forecasts of 715 million yuan, 834 million yuan, and 1.004 billion yuan respectively [3][4] Financial Summary - In 2024, the semiconductor segment generated revenue of 1.52 billion yuan, a year-on-year increase of 77.4%. The CMP polishing pad segment alone achieved revenue of 716 million yuan in 2024, up 71.51% year-on-year, and 220 million yuan in Q1 2025, up 63.14% year-on-year [4] - The company's gross profit margin for 2024 was 46.88%, an increase of 9.93 percentage points year-on-year, while the net profit margin was 19.14%, up 8.4 percentage points year-on-year. For Q1 2025, the gross profit margin was 48.82%, up 4.56 percentage points year-on-year, and the net profit margin was 20.44%, up 4.3 percentage points year-on-year [3][4] - The company’s total assets are projected to grow from 67.08 billion yuan in 2023 to 104.53 billion yuan in 2027, with total liabilities increasing from 18.32 billion yuan to 26.43 billion yuan over the same period [7]

Investment Rating - The report maintains a rating of "Accumulate" for the company [2][4][6] Core Views - The company experienced a revenue growth of over 50% year-on-year in 2024, driven by demand from North American major clients, although profits did not increase due to losses from subsidiaries and impairment provisions [4][9] - For 2025, growth is expected to diversify with significant contributions from the liquid cooling segment, automotive business, and thermal management products benefiting from capacity expansion in Vietnam [4][6] Summary by Relevant Sections Financial Performance - The company’s revenue for 2024 reached RMB 656 million, a 51.1% increase year-on-year, while net profit was RMB 52 million, a decrease of 3.9% [9] - The projected net profits for 2025, 2026, and 2027 are RMB 87 million, RMB 117 million, and RMB 150 million respectively, with corresponding P/E ratios of 38.9, 28.7, and 22.5 [6][8] Business Development - The company is expanding its business areas, including new projects in cooling fans, liquid silicone, electronic adhesives, and liquid cooling, which have led to significant growth in the automotive sector [9] - The investment in the Vietnam cooling product project has been increased from USD 35 million to USD 65 million, which is expected to enhance market share and profitability [9] Market Position - The company has successfully established partnerships with well-known clients in various sectors, including smart home, drones, and energy storage, and is working on certifications for key clients in AI servers and optical modules [9]

Investment Rating - The report assigns an "Accumulate" rating to the company, marking its first coverage with a positive outlook on the stock [1]. Core Views - The company is recognized as a leading domestic OLED terminal materials enterprise, benefiting from increasing downstream demand and the rising domestic production rate of OLED materials, which presents significant growth opportunities [1][6]. Summary by Sections Company Overview - The company specializes in the research, production, and sales of OLED organic materials, including OLED terminal materials and intermediates. It has achieved breakthroughs in domestic production and is one of the few companies capable of mass-producing OLED terminal materials [9][16]. Financial Performance - The company reported a revenue of RMB 472 million in 2024, representing a year-on-year growth of 56.9%. The net profit attributable to shareholders is projected to be RMB 167 million, with a significant increase of 116.7% [8][20]. Market Demand and Growth - The demand for OLED materials is expected to grow continuously due to the increasing penetration of OLED panels and the expansion of application scenarios. The domestic market for OLED organic materials is projected to reach RMB 4.3 billion in 2023, with a compound annual growth rate (CAGR) of 11% expected until 2030 [9][38]. Competitive Advantages - The company has a strong R&D capability, a comprehensive product line, and established relationships with major domestic panel manufacturers such as BOE and Huaxing. Its integrated production capabilities across the OLED supply chain enhance its competitive edge [9][17]. Valuation and Earnings Forecast - The report forecasts the company's net profits for 2024, 2025, and 2026 to be RMB 167 million, RMB 308 million, and RMB 459 million, respectively, with corresponding earnings per share (EPS) of RMB 0.41, RMB 0.77, and RMB 1.14 [6][8].